KK

Kunal Kumar

Active Director Director DIN 10858576
DIN 10858576 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunal Kumar

Data last updated:

Kunal Kumar is a Director at Iveron Remedies Private Limited (since 2026) and Director at Akunex Pharmaceuticals Private Limited (since 2024). The companies operate in Paper.

DIN 10858576
Primary Designation Director
Industry Paper
First Appointment 02 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iveron Remedies Private Limited U46497GJ2026PTC183060
Director31 Aug 20262026Active
Director02 Dec 20242024Under Process Of Striking Off

Board colleagues of Kunal Kumar

Directorship timeline

Open interactive timeline →
Akunex Pharmaceuticals Private Limited
Iveron Remedies Private Limited
Premium access

Shareholding and investment profile for Kunal Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Kumar

Kunal Kumar currently holds 2 directorships: Iveron Remedies Private Limited (Director, since 31 Aug 2026); Akunex Pharmaceuticals Private Limited (Director, since 02 Dec 2024).

Kunal Kumar was first appointed on 02 Dec 2024 as Director at Akunex Pharmaceuticals Private Limited. The most recent appointment on record is 31 Aug 2026 at Iveron Remedies Private Limited.

The current boards of Kunal Kumar's companies include Sangeeta Gupta (Iveron Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available